Amgen

Open: 227.84 Close: 227.43 Change: -0.41

Is Amgen Stock a good investment? This what an AI found.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, earnings, AMGN, NASDAQAMGN, late, price, company, and the most common words in the summary are: amgen, stock, amgn, inc, market, price, drug, . One of the sentences in the summary was: Amgen, Inc. Other searches related to this term that the AI found were: stockmarketlive, …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (AMGN) shareholders have earned a 5.8% CAGR over the last five years. The projected fair value for Amgen is US$407 based on 2 Stom Pgo pricesija Miko Escajajala. Amgen, Inc. (AMGN) stock price for Amgen (NASDAQ : AMGN ) is $ 227.43 last updated July 14, 2023 at 8:00 PM UTC. Amgen is in the Health Care sector and Biotechnology industry. Amgen, Inc. (AMGN) stock price for Amgen (NASDAQ : AMGN ) is $ 227.43 last updated July 14, 2023 at 8:00 PM UTC. Amgens Q2 earnings are confirmed for August 3, and there is no upcoming split.

Today's News

Barclays Maintains AMGEN (AMGN) Underweight Recommendation. Barclays maintains amgen (amgn) underweight recommendation. IFPA executive director Frida Dunger Johnsson, GHLF senior manager of BIPOC community outreach Sarah Shaw, and Amgen executive director of medical affairs Benoit Guerette speak about these efforts in this episode. In the summer of 2021, IFPA, with support from Amgen, issued a call for actionable solutions. Amgen (AMGN) shareholders have earned a 5.8% CAGR over the last five years Amgen Inc. (NASDAQ:AMGN): Here is What You Need to Know In the latest trading session, Amgen closed at $218.65, marking a -1.94% move from the previous day. The projected fair value for Amgen is US$407 based on 2 Stom Pgo pricesija Miko Esc0001 validItemTrackerGENQaedawings Rud Amgen is embracing the power and possibilities offered by artificial intelligence (AI), which will open the door to a new era of more rapid and profound innovation. Amgen received a Notice of Deficiency from the IRS in April 2022, which sought $5.1 billion in back taxes, plus interest, for tax years 2013, 2014, and 2015, and proposed a $2 billion penalty as a result of Amgens improper tax avoidance strategies. Amgen (AMGN) stock price, news, quotes-moomoo.com. The latest earnings per share (TTM) for the company is --. The latest financial report of Amgen, the latest earnings. The companys short percent of float has fallen 3.7%. Amgen announced a 60% cut in price on October 26, 2018 the maker of Repatha (evolocumab), the drug at that date cost $5,850 per year. Amgen is the worlds largest biotechnology firm and the largest employer in California. Amgen Inc. is a biotechnology company. Mike Zahigian occupies the position of Chief Information Officer & Senior Vice President. Amgen was established in Thousand Oaks, California, in 1980. Founded in 1983, Amgen went public on June 17, 1983, raising $40 million. Amgen was ranked 123 on the Fortune 500 list of the largest U.S. corporations by revenue. Amgen pleaded guilty and agreed to pay $150 million in criminal penalty and $612 million to resolve 11 related whistleblower complaints. Amgen reported Total CO2e emissions (Direct + Indirect) for the twelve months ending 31 December 2020 at 243 Kt (-6 /-2.4% y-o-y) and aims to reach net zero emissions by 2027. Amgen to buy Micromet for $1.2 billion. Amgen launches $200m biomanufacturing facility in Singapore Blinatumomab was the first CGRPR antagonist to be approved by the U.S. in May 2018. Erenumab was developed by Amgen and Novartis. Amgen is one of the worlds leading independent biotechnology companies. Credit Suisse analyst Trung Huynh maintains Amgen (NASDAQ:AMGN) with a Outperform and lowers the price target from $220 to $200. Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohns Disease. Amgen (NASDAQ:AMGN) reporting earnings are confirmed for Thursday, August 3, 2023. Amgen is in the Health Care sector and Biotechnology industry. The stock price for Amgen. is $ 227.43 last updated July 14. Amgen Inc. (NASDAQ: AMGN) Class Action Lawsuit and Lead Plaintiff Deadline of May 12, 2023. Celltrion launches biosimilar of AbbVies Humira. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q2 earnings are confirmed for Thursday, August 3, 2023. Q1 earnings are scheduled for August 3. There is no upcoming split for Amgen.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, earnings, AMGN, NASDAQAMGN, late, price, company, and the most common words in the summary are: amgen, stock, amgn, inc, market, price, drug, . One of the sentences in the summary was: Amgen, Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #amgn #inc #market #price #drug.